313 related articles for article (PubMed ID: 27178693)
1. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.
Kim C; Cheng J; Colegio OR
Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
Ritchie SA; Patel MJ; Miller SJ
Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
Herman S; Rogers HD; Ratner D
Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.
Willey A; Mehta S; Lee PK
Dermatol Surg; 2010 May; 36(5):652-8. PubMed ID: 19889154
[TBL] [Abstract][Full Text] [Related]
7. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):263-279. PubMed ID: 21763562
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
Endrizzi B; Ahmed RL; Ray T; Dudek A; Lee P
Dermatol Surg; 2013 Apr; 39(4):634-45. PubMed ID: 23379978
[TBL] [Abstract][Full Text] [Related]
9. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
10. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Leblanc KG; Hughes MP; Sheehan DJ
Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
[TBL] [Abstract][Full Text] [Related]
11. Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)".
Longo MI; Wen X; Womer KL
J Am Acad Dermatol; 2016 May; 74(5):e105-6. PubMed ID: 27085243
[No Abstract] [Full Text] [Related]
12. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
13. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
15. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Herold M; Good AJ; Nielson CB; Longo MI
Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
Gluck M; Hodak E; Davidovici B
Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
[TBL] [Abstract][Full Text] [Related]
17. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
Bangash HK; Colegio OR
Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
[TBL] [Abstract][Full Text] [Related]
18. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
19. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.
Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT
Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910
[TBL] [Abstract][Full Text] [Related]
20. Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
Jambusaria-Pahlajani A; Ortman S; Schmults CD; Liang C
Dermatol Surg; 2016 Jan; 42 Suppl 1():S66-72. PubMed ID: 26730976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]